Want to see TVGN full AI Analyst Report?
Tevogen Bio Holdings (TVGN) Income Statement
Tevogen Bio Holdings Income Statement
Last quarter (Q2 2026), Tevogen Bio Holdings's total revenue was $0.00. In Q2, Tevogen Bio Holdings's net income was $-5.76M. See Tevogen Bio Holdings’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Mar 25 | Mar 24 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ 0.00 | $ -403.58K | $ -378.36K | $ 0.00 | $ 0.00 | |
| $ 26.14M | $ 53.16M | $ 8.46M | $ 953.08K | $ 4.62M | |
| Depreciation and Amortization | $ 509.20K | $ 403.58K | $ 378.36K | $ 230.82K | $ 9.38K |
| $ -25.57M | $ -13.14M | $ -58.89M | $ 4.64M | $ -14.99M | |
| $ -26.14M | $ -53.56M | $ -8.84M | $ -953.08K | $ -4.62M | |
| $ -134.92K | $ 39.84M | $ -51.63M | $ 5.36M | $ -10.98M | |
| $ -26.28M | $ -13.73M | $ -60.48M | $ 4.41M | $ -15.60M | |
| $ -26.28M | $ -10.11M | $ -60.48M | $ 4.41M | $ -15.60M | |
| Per Share Metrics | |||||
| Basic EPS | $ -8.08 | $ -4.68 | $ -0.02 | $ 1.83 | $ -16.50 |
| Diluted EPS | $ -8.08 | $ -4.68 | $ -0.02 | $ 1.83 | $ -16.50 |
| Weighted Average Shares Outstanding | 3.32M | 2.93M | 3.31M | 2.40M | 958.67K |
| Weighted Average Shares Outstanding (Diluted) | 3.32M | 2.93M | 3.31M | 2.40M | 958.67K |
Currency in USD
